Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: benefits of a dietary myo-inositol supplementation

The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol

(2014) Hao-Han Chang et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Potential role and therapeutic interests of myo-inositol in metabolic diseases

(2013) Marine L. Croze et al.   BIOCHIMIE

myo-Inositol Supplementation and Onset of Gestational Diabetes Mellitus in Pregnant Women With a Family History of Type 2 Diabetes: A prospective, randomized, placebo-controlled study

(2013) R. D'Anna et al.   DIABETES CARE

Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study

(2013) P. G. Artini et al.   GYNECOLOGICAL ENDOCRINOLOGY

Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial

(2013) Barbara Matarrelli et al.   Journal of Maternal-Fetal & Neonatal Medicine

Herbal constituent sequoyitol improves hyperglycemia and glucose intolerance by targeting hepatocytes, adipocytes, and β-cells

(2012) Hong Shen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials

(2012) V. Unfer et al.   GYNECOLOGICAL ENDOCRINOLOGY

Chronic treatment with myo-inositol reduces white adipose tissue accretion and improves insulin sensitivity in female mice

(2012) Marine L. Croze et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome

(2011) A. Santamaria et al.   CLIMACTERIC

Transcriptional and Post-translational Modulation ofmyo-Inositol Oxygenase by High Glucose and Related Pathobiological Stresses

(2011) Baibaswata Nayak et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome

(2010) Domenico Giordano et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Myo-Inositol Treatment Increases Serum Plasmalogens and Decreases Small Dense LDL, Particularly in Hyperlipidemic Subjects with Metabolic Syndrome

(2008) Ryouta MAEBA et al.   JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY